Why the study?
What is the contribution of comorbidities to the mortality hazard in patients with NSTEMI?
What is the contribution of comorbidities to the mortality hazard in patients with NSTEMI?
NSTEMI independently increases mortality hazard beyond the risk contributed by comorbid conditions, highlighting the need for more effective management strategies.
May inform comorbidity-adjusted risk models in NSTEMI; leaves open whether intensified strategies improve survival in trials.
NSTEMI confers a significantly higher mortality hazard beyond what can be attributed to comorbid conditions. More consistent and effective strategies are needed to reduce mortality in NSTEMI amid comorbid conditions.
No takes yet. Share an insight, caveat, or question.
Foraker et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: